![香港合宝典 香港合宝典](/rc/img/claim/home/hra.jpg)
Our purpose
Improve people's lives
![香港合宝典 香港合宝典](/rc/img/area/areas-terapeuticas.jpg)
Therapeutic areas
Find out more![Contract Manufacturing](/rc/img/area/cmo2.png)
Contract Manufacturing
Find out more![香港合宝典 香港合宝典](/rc/img/area/i+d.jpg)
R&D
Find out more![香港合宝典 香港合宝典](/rc/img/area/pacientes.jpg)
Patients
Find out moreAbout us
Learn how we've been delivering on our mission for patients for 90 years.
Media
![香港合宝典 香港合宝典](/GetFichero.do?con=3670&zon=3&fichero=Ar_3_3_3670_IL_1.jpg)
ESTEVE ACQUIRES HRA PHARMA RARE DISEASES
This expands ESTEVE's portfolio of medications for rare and severe diseases with three products to treat Cushing's syndrome and adrenocortical carcinoma; and drives its intern...
10/07/2024
Read more![香港合宝典 香港合宝典](/GetFichero.do?con=3669&zon=3&fichero=Ar_3_3_3669_IL_1.jpg)
ESTEVE WILL INVEST 100 MILLION EUROS IN THE CONSTRUCTION OF A NEW PLANT AT ITS INDUSTRIAL CENTRE IN CELRÀ (GIRONA)
The company expects the new facilities to be operational in the last quarter of 2026.
This unit will allow the company's production capacity to increase globally ...
28/06/2024
Read more![香港合宝典 香港合宝典](/GetFichero.do?con=3668&zon=3&fichero=Ar_3_3_3668_IL_1.jpg)
ESTEVE CONSOLIDATES ITS DOUBLE-DIGIT GROWTH AND REACHES €710 MILLION IN NET INCOME
The company advances in its vision to be a leading international specialty pharmaceutical company, growing in Europe and expanding the portfolio
ESTEVE's medicine...
16/05/2024
Read more![Our global presence](/rc/img/area/presencia-mundo.png)
Our global presence
Get our latest news and media resources
Go![香港合宝典 香港合宝典](/rc/img/claim/media/corporate-resources/discover.jpg)